9,891 Shares in HCA Healthcare, Inc. $HCA Bought by Banque Pictet & Cie SA

Key Points

• Banque Pictet & Cie SA initiated a position in HCA Healthcare during the third quarter, purchasing 9,891 shares valued at approximately $4.2 million. Institutional investors and hedge funds collectively own 62.73% of the company.
• HCA Healthcare exceeded quarterly expectations, reporting $7.59 in EPS and $20.23 billion in revenue, with revenue rising 8.7% year over year.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $467.61; HCA also pays a quarterly dividend of $0.78 per share.

Banque Pictet & Cie SA bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 9,891 shares of the company's stock, valued at approximately $4,221,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Sunbelt Securities Inc. lifted its position in HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock worth $2,954,000 after acquiring an additional 3,945 shares during the last quarter. Sei Investments Co. grew its position in shares of HCA Healthcare by 27.5% in the first quarter. Sei Investments Co. now owns 467,796 shares of the company's stock valued at $221,380,000 after purchasing an additional 100,764 shares during the last quarter. SEB Asset Management AB bought a new position in shares of HCA Healthcare in the first quarter worth about $75,534,000. OP Asset Management Ltd acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $12,883,000. Finally, Darsana Capital Partners LP boosted its stake in HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company's stock valued at $428,879,000 after purchasing an additional 350,000 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $458.39 on Friday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The firm has a market capitalization of $99.24 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 1.55 and a beta of 1.10. The company's fifty day moving average price is $426.39 and its two-hundred day moving average price is $419.27.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $6.84 EPS. Analysts predict that HCA Healthcare, Inc. will post 29.45 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were paid a dividend of $0.78 per share. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HCA. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a research note on Monday, July 27th. TD Cowen upped their target price on shares of HCA Healthcare from $431.00 to $460.00 and gave the company a "buy" rating in a research note on Monday, October 12th. The Goldman Sachs Group reduced their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a report on Tuesday, July 28th. BMO Capital Markets initiated coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They set an "outperform" rating and a $495.00 price objective on the stock. Finally, Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a research report on Monday, August 3rd. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $467.61.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.